Clinical Trial Update: Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating recombinant human activated coagulation factor VII for injection in patients with hemophilia with inhibitor is ongoing, status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Recombinant human activated coagulation factor VII for injection (Coagulation factor VII)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Hemophilia A, Hemophilia B | Phase 3 | Status: UNKNOWN